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A B S T R A C T
Purpose: Cerebral cavernous malformations (CCMs) are frequently associated with intractable epilepsy.
Whereas surgery indication in single CCMs is clear, data regarding the efﬁcacy of epilepsy surgery in
patients with multiple CCMs are scarce. We sought to clarify diagnostic requirements and postoperative
outcome in patients with multiple CCMs and refractory epilepsy.
Methods: Retrospective analysis of clinical records of hospitalized patients who underwent compre-
hensive diagnostic work-up including long-term video-EEG monitoring.
Results: From a total of 63 consecutive patients with CCMs and medically refractory epilepsy, 11 (17%)
hadmultiple CCMs and underwent epilepsy surgery. There were three females and eightmales. Mean age
at epilepsy onset was 28.3 years (S.D. 12.3), and at epilepsy surgery, 40.7 years (S.D. 10.3). On average,
each patient had 3.7 (S.D. 2.2) supratentorial CCMs. In all cases we identiﬁed only one epileptogenic zone.
The epileptogenicity was higher for the CCMs located within the temporal lobe. At 2 years follow-up, the
outcome according to the Engel classiﬁcation was Ia (seizure-free) in nine patients (81.8%) and IIb (rare
seizures) and IVc (worsening) in two patients, respectively. In one patient, a dual pathology was present
and, in another case, de novo appearance of CCMs was demonstrated.
Conclusions: Our results show that postoperative outcome in patients withmultiple CCMs can be as good
as in those with single malformations if proper presurgical identiﬁcation of the epileptogenic CCMs is
done. The possibility of the novo appearance of CCMs or dual pathology may occur and may affect long-
term outcome negatively.
 2008 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Cerebral cavernousmalformations (CCMs) – or cavernomas – are
increasingly recognized as a cause of partial epilepsy.1 Approxi-
mately 4% of the medically refractory epilepsies are related to
CCMs.2 On the other hand, the most common clinical presentation
(38–51%) in affected patients are seizures.3–5
In patients with single CCMs harboring medically intractable
epilepsy and concordant topographic and neurophysiologic ﬁnd-
ings, there is a clear indication for epilepsy surgery. This is
particularly true, since surgical series in patients with solitary
CCMs show favorable results with 80–90% seizure-free patients* Corresponding author. Present address: Department of Neurology, Hospital
Ruber Internacional, C/ La Maso´ 38, Madrid E-28034, Spain. Tel.: +34 91 3875250;
fax: +34 91 3875333.
E-mail addresses: rrocamora@ruberinternacional.es, rrocamor@hotmail.com
(R. Rocamora).
1059-1311/$ – see front matter  2008 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2008.10.006after surgery.2,5–7 However, no accepted guideline regarding the
diagnostic protocol or the optimal management of patients with
multiple CCMs exist. The presence of two or more potentially
epileptogenic lesions means a considerable diagnostic challenge in
the presurgical evaluation of these patients.
The prevalence of CCMs in the general population is unknown.
Estimations provided by postmortem studies show a frequency
between 0.02 and 0.5%.8–10 The prevalence of multiple cavernomas,
in patients with diagnosis of CCM, has been estimated by MRI
and reported to range between 231 and 50%.11Multiple lesionsmay
occurmore commonly in hereditary cases12 and have been found to
be over-represented in Hispanic population. Moreover, it has been
found that multiple lesions are more common in females.13
Associated genes have been mapped in Hispanic, German and
French families.14–16
Here, we describe 11 consecutive patients with multiple CCMs
and focal medically refractory epilepsy who underwent epilepsy
surgery in our center.vier Ltd. All rights reserved.
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We reviewed retrospectively the ﬁles of all patients with
focal epilepsy who were evaluated at our epilepsy center during
a 8-year period (1999–2007). A total of 750 ﬁles were screened
for cavernous malformations.
On admission, all patients were examined routinely, including
brainMRI on a SiemensMagnetomVision (1.5 T) with T1, T2, FLAIR
and FLASH gradient echo sequences. Additionally, three patients
had PET and SPECT. All patients underwent presurgical evaluation
with long-term video-EEG monitoring, as well as neuropsycholo-
gical, and psychiatric testing.
During monitoring, standard antiepileptic drugs (AEDs) were
partially or totally discontinued in all cases. Long-term video-EEG
monitoring was performed using surface electrodes placed
according to the international 10–20 system, with selective use
of additional Sp1/Sp2 sphenoidal electrodes. Only one patient
underwent extraoperative invasive electrocorticography (ECoG).
Comprehensive electrophysiological data obtained from con-
tinuous video-EEG/ECoG recordings were analyzed. Ictal EEG
activity was evaluated for lateralization, location of seizure onset
and propagation in order to correlate this information with: (1)
MRI localization of malformations, (2) the presumed epilepto-
genicity of different lesions, and (3) with semiological phenomena
observed during digital video-monitoring.
3. Results
3.1. Clinical data
From a total of 63 consecutive patients evaluated in our
center with CCMs and medically refractory epilepsy, eleven
patients (17%) withmultiple CCMswere considered to be surgical
candidates and underwent epilepsy surgery. There were three
females and eightmales, with amean age of 45.4 years (range 27–
57 years, S.D. 9.2 years).
Mean age at seizure onsetwas 28.3 years (S.D. 12.3 years).Mean
age at epilepsy surgery was 40.7 years (S.D. 10.3 years) (Table 1).
3.2. Clinical manifestations
In all patients the ﬁrst clinical manifestation was epilepsy. One
patient suffered also from migrainous headaches. Two patients
showed signs of recent bleeding on MR-imaging at diagnosis of
epilepsy. Neurological examination was normal in all patients.
3.3. Seizure types and frequency
The mean frequency of seizures was 14 per month. All patients
had partial seizures (nine patients complex partial and eightTable 1
Epidemiological data.
Age Sex Age at epilepsy
begin
Age at
surgery
No. of supr.
cavernomas
Pat. 1 39 m 23 27 2
Pat. 2 53 f 43 48 5
Pat. 3 40 m 32 38 4
Pat. 4 55 m 46 51 2
Pat. 5 27 m 19 21 6
Pat. 6 41 m 32 39 2
Pat. 7 49 m 43 43 4
Pat. 8 43 f 16 38 3
Pat. 9 57 f 30 56 9
Pat. 10 40 m 8 38 2
Pat. 11 55 m 20 49 2simple partial seizures), eight additionally suffered from secondary
generalized seizures.
3.4. Family history
A positive family history for multiple CCMs was present at ﬁrst
evaluation in six patients (54%); in four of them (36%), CCMs were
associated with epilepsy.
3.5. Topographical distribution of supratentorial CCMs
On average, each patient had 3.7 (S.D. 2.2) supratentorial CCMs
at presurgical evaluation (Fig. 1). In one patient (patient 3) the
formation of new CCMs after surgery was demonstrated by
repeated MRI examinations.
From a total of 41 supratentorial CCMs, 16were frontal (39%), 11
temporal (27%), 9 parietal (22%), 3 occipital (7%) and 2 insular (5%)
(Fig. 2). Five patients (45%) had also additional infratentorial CCMs.
3.6. Relationship between localization, size and epileptogenicity
According to presurgical evaluation, we found a total of 14
epileptogenic CCMs in our 11 patients. With respect to epilepto-Fig. 1. Patient 9 presents multiple potentially epileptogenic supratentorial CCMs at
the time of presurgical evaluation.
Fig. 2. Topographical distribution of supratentorial CCMs.
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in the parietal lobe (21%), two in the frontal lobe (14%) and one in
the insula (7%). In three cases, two adjacent CCMswere found to be
epileptogenic and resected in the same procedure (cases 6, 8 and
9). Two of them were located in the temporal lobe and one in the
frontal lobe. Considering the relationship between epileptogeni-
city and localization, we found that 2 of 16 frontal, 3 of 9 parietal
and 8 of 11 temporal CCMs were epileptogenic, showing a
proportion of 0.12, 0.33 and 0.72, respectively (Fig. 3).
We also measured the diameter of the largest (range 8.8–
56.9 mm) and the operated cavernoma. Only in 6 out of 11 (54%)
patients the largest cavernomawas considered to be epileptogenic
and therefore resected.Fig. 3. Localization of epileptogenic CCMs.In seven patients with TLE, we calculated the distance between
the resected CCM and the hippocampus, in order to determine its
signiﬁcance in the therapeutic procedure. On average, the distance
was 9.44 mm (range 0.2–28.8). In one patient, who underwent
amygdalohippocampectomy with CCM resection, the distance
between lesion and hippocampus was 0.9 mm.
3.7. Diagnostic EEG procedure
All but one patient were studied with long-term video-EEG
monitoring using non-invasive recordings. Implanted electrodes
were used in only one case for language localization in a patient
with close spatial relationship between the cavernoma and
Wernicke’s area and unclear ﬁndings in both, Wada testing and
f-MRI. In ten patients ictal events were registered, and in one
patient only interictal activity. In all patients a detailed semiologic
analysis of each seizurewas performed in order to correlate seizure
onset area and lesion localization.
Interictal activity concordant to the suspected epileptogenic
lesion in the form of sharp-waves was found in nine patients.
However, interictal spiking unrelated to the zone of seizure onset
was present in four patients. Interestingly, in three cases additional
CCMs were found in these areas (unrelated irritative zone). During
the video-EEG monitoring in which AEDs were gradually tapered
off, no complications or medically hazardous situations occurred.
3.8. Surgical procedure
In seven patients extended lesionectomy of a single cavernoma
including the contiguous hemosiderin (yellow dyed) containing
tissue was performed. In three other patients, extended resection
of two adjacent CCMs was done (patients 6, 8 and 9), and in an
additional patient with a dual pathology (patient 5) amygdalo-
hippocampectomy was performed in addition to lesionectomy.
Patients 1 and 10 had been previously operated without
extensive presurgical evaluation and without favorable seizure
outcome. In patient 1, a resection of right parietal CCMwas carried
out. In patient 10, a resection of a left sided cavernoma located in
the superior temporal gyrus was performed years before and now,
a lesionectomy of a left mesial temporal cavernoma with a
temporal pole resection was done.
Neuronavigation was routinely used during the surgical
procedures in all patients. Remaining hemosiderin rests were
found on MRI examinations 3 months after the surgery in 8 out of
11 patients.
3.9. Complications after surgery
Four patients suffered from expected visual ﬁeld defects
directly resulting from the surgical procedure. One patient (patient
4), in whom amygdalohippocampectomy was combined with
extended lesionectomy, had a residual minor hemiparesis and
dysphasia, due to an infarction near the internal capsula.
3.10. Histopathology
A CCM with associated hemosiderin deposits was conﬁrmed
histopathologically in all patients.
3.11. Seizure outcome
The outcome according to the Engel classiﬁcation was Ia
(seizure-free) in ten patients and Ib (only auras) in one patient 6
months postoperatively. At 1-year follow-up, two initially seizure-
free patients deteriorated and were actually IIb (rare seizures) and
Table 2
Postoperative seizure outcome (Engel).
Out. Engel
3 months 6 months 12 months 24 months
Pat. 1 Ia Ia IVc IVc
Pat. 2 Ia Ia Ia Ia
Pat. 3 Ia Ia Ia Ia
Pat. 4 Ib Ib Ib Ia
Pat. 5 Ia Ia Ia Ia
Pat. 6 Ia Ia Ia Ia
Pat. 7 Ia Ia Ia Ia
Pat. 8 Ia Ia Ia Ia
Pat. 9 Ia Ia Ia Ia
Pat. 10 Ia Ia IIb IIb
Pat. 11 Ia Ia Ia Ia
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worsening in the seizure outcome was observed (Table 2). In
contrast, one patient who initially had only auras became seizure-
free. In two out of three patients without complete seizure control,
an incomplete hemosiderin ring resection was observed on
postoperative MRI. Nevertheless, seven other patients who were
seizure-free had some hemosiderin rests on postoperative MRI.
4. Discussion
It has been shown that approximately 4% of pharmacoresistant
focal epilepsies are caused by CCMs.17,18 As expected, focal
seizures are the most common clinical presentation form in CCMs,
including simple, complex and generalized seizures.19,20 CCMs are
twice as likely associatedwith seizures when comparedwith other
lesions, such as AVMs and tumors with similar volume distribu-
tions and identical locations.21 The pathophysiological basis of
seizures in CCMs seems to refer to micro-hemorrhages with the
exposure of the surrounding brain to blood breakdown products,
particularly iron and the subsequent gliotic reaction.22,23 In follow-
up studies modiﬁcations in size and signal characteristics of the
lesions have been observed.24 Moreover the development of
secondary epileptogenic foci should be considered in patients with
dual pathology.25
Longtime studies of patients with symptomatic epilepsy and
CCMs are lacking. The optimal management is still a matter of
debate.26 In particular, the presence of multiple CCMs demands
accurate presurgical diagnostic work-up to precisely localize
seizure origin.
In our series, mean age of patients at ﬁrst seizure was 28.3
years. Seizure control with AEDs was disappointing, and few years
after onset of epilepsy it was evident that the seizures were nor
controlled with AEDs. However, the mean time until epilepsy
surgery was considerably long (12.3 years). This fact strongly
indicates that epilepsy surgery should be considered early after
diagnosis of a pharmacoresistant epilepsy. Furthermore, the mean
seizure frequency was relatively high (14 per month), but in no
case status epilepticus was noted.
Six of our patients (54%) had a positive family history for
multiple CCMs, although we cannot rule out the existence of silent
lesions in the other families. Considering that the possibility to ﬁnd
a positive hereditary trait is high, the option to perform a MRI in
ﬁrst-degree family members should be discussed, in particular if
there is a history of headache, seizures or stroke and related
symptoms.
We used the 10–20 BBG-system with facultatively additional
sphenoidal electrodes to identify the epileptogenic area. Only in
one bilateral-handed patient an invasive procedure was required
due to unclear lateralization of language.Through video-EEG we could localize the zone of seizure onset
(SO) adequately in nine patients. In none of them we found EEG
data suggesting additional seizure foci, although in four patients
we had evidence of interictal epileptic activity unrelated to SO. Of
the remaining two patients ictal EEG analysis was not possible due
to artefacts in one case (patient 4), and absent seizures in the
second patient (patient 6) despite complete AED withdrawal. In
these cases, a careful analysis of seizure semiology and interictal
spiking, respectively in correlation with cavernoma localization
was sufﬁcient to determinate seizure origin.
Seizure outcome 1 year after lesionectomy in our series showed
that nine patients (81%) remained free of seizures or had only auras
(Engel I). At 2 years follow-up, no deterioration was noted.
Unexpected surgical complications were observed in only one
patient (patient 5).
The serialMRI controls revealed postoperative hemosiderin rest
in 8 out of 11 patients. It seems to be remarkable that the two
patients with persistent seizures have hemosiderin rests. Most
authors share the opinion that extended lesionectomy results in
better seizure outcome.27–29 However, other studies did not ﬁnd
evidence supporting this hypothesis.6,30,31
We did not ﬁnd any positive correlation between number of
CCMs, seizure frequency, and postoperative outcome. Postopera-
tive seizure outcome in our series indicates that only the resected
CCMs were responsible for the seizure generation. The favorable
outcome of two patients who had been unsuccessfully operated
without correct diagnosis after exact determination of the
epileptogenic CCM speaks in favor of thorough preoperative
work-up. In both cases the diagnostic procedure demonstrated
that the operated cavernoma had not been the epileptogenic
lesion, corresponding to the poor seizure outcome. Thus, when
more than one lesion is located in the epileptogenic zone, resection
of all malformations may offer advantages if there is no additional
risk of neuropsychological or motor deﬁcits. Furthermore, in cases
in which the CCMs are very close to each other a neurophysio-
logical differentiation of the individual epileptogenicity of each
cavernoma through superﬁcial EEG is usually not possible.
De novo appearance of CCMs has been demonstrated pre-
viously.32,33 At least in one case (patient 2), we observed the novo
appearance of CCMs 3 years after the epilepsy surgery. The
appearance of new lesions, possibly higher in patients with a
hereditary trait, could be a factor negatively inﬂuencing seizure
control. This possibility imposes, in case of seizure recurrence, the
necessity of serial MRI examinations and eventually repeated
video-EEG monitoring.
On the other hand, dual pathology, i.e. the coexistence of
temporo-mesial sclerosis and, in this case, one or more temporal
CCMs were observed in another patient. In this situation, it can be
particularly difﬁcult to identify the lesion responsible for seizure
generation. From an epileptological point of view, seizure
semiology and EEG characteristics of seizure onset can provide
information in order to differentiate a mesial or lateral seizure
origin. Nonetheless, thorough distinction may not be possible if
there is rapid propagation of epileptic activity. In this situation,
invasive diagnostic work-up with intraoperative/perioperative
ECoG and implementation of more sensitive MRI-techniques, can
provide the necessary information in order to clarify the
epileptogenic area. Consequently, in temporal lobe CCMs, due to
potentially relevant memory deﬁcits, an additional hippocam-
pectomy should only be performed if there is clear evidence of its
involvement in seizure generation.
The distribution of supratentorial CCMs corresponded roughly
the volume proportion of each cerebral lobe. However the
epileptogenicity, i.e. the capability to generate seizures, was
higher in the temporal lobe. Although temporal CCMs represented
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of epileptogenic CCMs. It has been suggested that temporal lobe
CCMs are more likely to be associated with intractability of
seizures.30 The opposite holds for the frontal lobe: whereas 39% of
CCMs were found, only 14% of there were epileptogenic. However,
this is not generally accepted.1
Measuring the maximal diameter of the CCMs, we could not
ﬁnd any clear relationship between size of the CCM and its
epileptogenicity. Only in 54% of patients, the largest cavernoma
was involved in the generation of seizures. The distance between
the vascular malformation and the hippocampal formation did not
inﬂuence the surgical procedure, although the average distance
was only 9.4 mm (range 0.2–28.8).
5. Conclusions
A retrospective study of patients with medically refractory
epilepsy and multiple supratentorial CCMs who underwent
epilepsy surgery at our epilepsy center is presented. We conclude
from our limited experience that the postoperative outcome of
patients withmultiple CCMs seems to be as favorable as of patients
with single lesions. Therefore, surgical treatment in multiple CCMs
should be considered early after recognition of seizure intract-
ability. In most cases, invasive diagnostic procedures are not
necessary. Nonetheless, the possibility of a de novo appearance of
CCMs and, as a result, the development of new epileptogenic foci
should be recognized.
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